Safety, effectiveness, and cost of long-acting versus intermediate-acting insulin for type 1 diabetes: Protocol for a systematic review and network meta-analysis

BACKGROUND: Type 1 diabetes mellitus (T1DM) causes progressive destruction of pancreatic beta cells leading to absolute insulin deficiency. Treatment of T1DM requires insulin, and some evidence suggests that longer acting insulin analogues might have a higher effectiveness and greater safety profile...

Descripción completa

Detalles Bibliográficos
Autores principales: Tricco, Andrea C, Ashoor, Huda M, Soobiah, Charlene, Hemmelgarn, Brenda, Moher, David, Hutton, Brian, Yu, Catherine H, Majumdar, Sumit R, Straus, Sharon E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3847127/
https://www.ncbi.nlm.nih.gov/pubmed/24020869
http://dx.doi.org/10.1186/2046-4053-2-73

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3847127/
https://www.ncbi.nlm.nih.gov/pubmed/24020869
http://dx.doi.org/10.1186/2046-4053-2-73

Ejemplares similares